Halozyme Therapeutics Inc (HALO)
64.87
+0.85
(+1.33%)
USD |
NASDAQ |
Mar 25, 16:00
64.87
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Price to Book Value: 21.96 for March 25, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.413 |
| Johnson & Johnson | 5.428 |
| Catalyst Pharmaceuticals Inc | 4.292 |
| Merck & Co Inc | 4.792 |
| Semler Scientific Inc | 1.761 |
Price to Book Value Related Metrics
| PE Ratio | 18.91 |
| PS Ratio | 8.264 |
| PEG Ratio | 0.3024 |
| Price to Free Cash Flow | 17.91 |
| Price | 64.87 |
| Earnings Yield | 5.29% |
| Market Cap | 7.989B |
| PEGY Ratio | 0.3024 |
| Operating PE Ratio | 15.21 |
| Normalized PE Ratio | 19.76 |